[TNXP] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
08-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -3.70%
YoY- -16.31%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 33,902 0 9,739 9,027 0 0 0 -
PBT -33,005 -31,680 -28,981 -23,140 -26,417 -29,553 -18,528 47.00%
Tax -1,790 5,611 -610 -196 -19 -92,420 0 -
NP -33,005 -34,084 -28,981 -27,395 -26,417 -29,553 -18,528 47.00%
Tax Rate - - - - - - - -
Total Cost 66,907 34,084 38,720 36,422 26,417 29,553 18,528 135.56%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -100.00 0.00 -291.31 -254.17 0.00 0.00 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -102.85 -111.06 -135.52 -244.55 -321.28 -419.18 -319.96 -53.10%
EPS Diluted -102.85 -111.06 -135.52 -244.55 -321.28 -419.18 -319.96 -53.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.